The successful commercial deployment of a newly approved grass pollen immunotherapy is expected to establish a foundation for long-term profitability at Allergy Therapeutics PLC, according to broker analysis from Cavendish.
All posts tagged in pharmaceutical stocks
4Articles
Citi has increased its price target for GSK PLC (LSE:GSK, NYSE:GSK) to £22.50 whilst maintaining a neutral rating on the pharmaceutical group following a notable rally in the shares driven
Recent clinical trials have unveiled a significant breakthrough in the potential application of weight-loss medication Semaglutide, marketed as Wegovy, in reducing alcohol consumption. The groundbreaking study demonstrated a remarkable 40%
Share prices of leading vaccine developers experienced significant gains on Tuesday following the announcement of America’s first human death from the H5 strain of bird flu. The market response saw
